HK1147481A1 - Polymorphic form - Google Patents

Polymorphic form

Info

Publication number: HK1147481A1
Authority: HK; Hong Kong
Prior art keywords: polymorphic form; polymorphic
Prior art date: 2008-02-04

Application number

HK11101504.4A

Other languages

English (en)

Chinese (zh)

Inventor

‧布徹

Original Assignee

輝瑞有限公司

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-02-04

Filing date

2011-02-16

Publication date

2011-08-12

2011-02-16 Application filed by 輝瑞有限公司 filed Critical 輝瑞有限公司

2011-08-12 Publication of HK1147481A1 publication Critical patent/HK1147481A1/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Oncology (AREA)
Rheumatology (AREA)
Immunology (AREA)
Diabetes (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Neurology (AREA)
Virology (AREA)
Hematology (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Molecular Biology (AREA)
Ophthalmology & Optometry (AREA)
Biomedical Technology (AREA)
Tropical Medicine & Parasitology (AREA)
Neurosurgery (AREA)
AIDS & HIV (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)

HK11101504.4A 2008-02-04 2011-02-16 Polymorphic form HK1147481A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US2587908P	2008-02-04	2008-02-04
PCT/IB2009/050351 WO2009098612A2 (en)	2008-02-04	2009-01-28	Polymorphic form of a [1, 2, 4] triazolo [4, 3-a] pyridine derivative for treating inflammatory diseases

Publications (1)

Publication Number	Publication Date
HK1147481A1 true HK1147481A1 (en)	2011-08-12

Family

ID=40911989

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK11101504.4A HK1147481A1 (en)	2008-02-04	2011-02-16	Polymorphic form

Country Status (23)

Country	Link
US (1)	US8222273B2 (sl)
EP (1)	EP2303267B1 (sl)
JP (1)	JP5344942B2 (sl)
KR (2)	KR101422318B1 (sl)
CN (1)	CN101939320B (sl)
AR (1)	AR070411A1 (sl)
AU (1)	AU2009211072B2 (sl)
BR (1)	BRPI0907463A2 (sl)
CA (1)	CA2712574C (sl)
CY (1)	CY1114389T1 (sl)
DK (1)	DK2303267T3 (sl)
ES (1)	ES2423991T3 (sl)
HK (1)	HK1147481A1 (sl)
IL (1)	IL206948A (sl)
MX (1)	MX2010008535A (sl)
NZ (1)	NZ587094A (sl)
PL (1)	PL2303267T3 (sl)
PT (1)	PT2303267E (sl)
RU (1)	RU2448966C1 (sl)
SI (1)	SI2303267T1 (sl)
TW (1)	TWI391391B (sl)
WO (1)	WO2009098612A2 (sl)
ZA (1)	ZA201005137B (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0905955D0 (en)	2009-04-06	2009-05-20	Respivert Ltd	Novel compounds
CN103200938B (zh)	2010-08-30	2018-07-31	普马特里克斯营业公司	干燥粉末配方及用于治疗肺部疾病的方法
EP2448571B1 (en)	2010-08-30	2013-06-12	Pulmatrix, Inc.	Respirably dry powder comprising calcium lactate, sodium chloride and leucine
ES2899621T3 (es)	2010-09-29	2022-03-14	Pulmatrix Operating Co Inc	Polvos secos catiónicos que comprenden sal de magnesio
US20140336159A1 (en)	2011-10-07	2014-11-13	Pulmatrix, Inc.	Methods for treating and diagnosing respiratory tract infections
US9458154B2 (en)	2011-12-09	2016-10-04	Chiesi Farmaceutici S.P.A.	Kinase inhibitors
CN105646484A (zh) *	2016-03-01	2016-06-08	孙霖	晶型b及制备方法
CN105693716A (zh) *	2016-03-01	2016-06-22	孙霖	晶型a及制备方法
GB201721793D0 (en)	2017-12-22	2018-02-07	Hvivo Services Ltd	Methods and compunds for the treatment or prevention of hypercytokinemia and severe influenza

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HRP990182A2 (en)	1998-06-11	2000-02-29	Du Pont Pharm Co	Crystalline efavirenz
CA2351727C (en) *	1998-11-20	2008-09-23	Mitsubishi Chemical Corporation	Crystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione
US7847112B2 (en)	2004-07-16	2010-12-07	Health Science Funding, LLC	Polymorphs of atovaquone and process of preparation thereof
GB0418015D0 (en) *	2004-08-12	2004-09-15	Pfizer Ltd	New compounds
AU2005273612B2 (en) *	2004-08-12	2010-10-14	Pfizer Inc.	Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors

2009
- 2009-01-28 US US12/865,889 patent/US8222273B2/en not_active Expired - Fee Related
- 2009-01-28 MX MX2010008535A patent/MX2010008535A/es active IP Right Grant
- 2009-01-28 EP EP09708402.4A patent/EP2303267B1/en not_active Not-in-force
- 2009-01-28 KR KR1020107016846A patent/KR101422318B1/ko not_active IP Right Cessation
- 2009-01-28 RU RU2010132639/04A patent/RU2448966C1/ru not_active IP Right Cessation
- 2009-01-28 BR BRPI0907463A patent/BRPI0907463A2/pt not_active IP Right Cessation
- 2009-01-28 KR KR1020137015900A patent/KR20130087048A/ko not_active Application Discontinuation
- 2009-01-28 PT PT97084024T patent/PT2303267E/pt unknown
- 2009-01-28 DK DK09708402.4T patent/DK2303267T3/da active
- 2009-01-28 ES ES09708402T patent/ES2423991T3/es active Active
- 2009-01-28 CN CN2009801041294A patent/CN101939320B/zh not_active Expired - Fee Related
- 2009-01-28 SI SI200930680T patent/SI2303267T1/sl unknown
- 2009-01-28 AU AU2009211072A patent/AU2009211072B2/en not_active Ceased
- 2009-01-28 WO PCT/IB2009/050351 patent/WO2009098612A2/en active Application Filing
- 2009-01-28 CA CA2712574A patent/CA2712574C/en not_active Expired - Fee Related
- 2009-01-28 NZ NZ587094A patent/NZ587094A/en not_active IP Right Cessation
- 2009-01-28 PL PL09708402T patent/PL2303267T3/pl unknown
- 2009-02-02 JP JP2009021286A patent/JP5344942B2/ja not_active Expired - Fee Related
- 2009-02-03 AR ARP090100349A patent/AR070411A1/es unknown
- 2009-02-03 TW TW098103398A patent/TWI391391B/zh not_active IP Right Cessation
2010
- 2010-07-12 IL IL206948A patent/IL206948A/en not_active IP Right Cessation
- 2010-07-19 ZA ZA2010/05137A patent/ZA201005137B/en unknown
2011
- 2011-02-16 HK HK11101504.4A patent/HK1147481A1/xx not_active IP Right Cessation
2013
- 2013-08-14 CY CY20131100704T patent/CY1114389T1/el unknown

Also Published As

Publication number	Publication date
AU2009211072A1 (en)	2009-08-13
AR070411A1 (es)	2010-04-07
CA2712574C (en)	2014-01-07
CY1114389T1 (el)	2016-08-31
IL206948A (en)	2014-12-31
RU2448966C1 (ru)	2012-04-27
JP2009185028A (ja)	2009-08-20
PL2303267T3 (pl)	2013-11-29
EP2303267B1 (en)	2013-07-03
MX2010008535A (es)	2010-08-30
CN101939320A (zh)	2011-01-05
ES2423991T3 (es)	2013-09-26
DK2303267T3 (da)	2013-09-02
EP2303267A2 (en)	2011-04-06
US8222273B2 (en)	2012-07-17
KR20130087048A (ko)	2013-08-05
KR20100108409A (ko)	2010-10-06
JP5344942B2 (ja)	2013-11-20
NZ587094A (en)	2011-07-29
CA2712574A1 (en)	2009-08-13
PT2303267E (pt)	2013-08-05
KR101422318B1 (ko)	2014-07-22
WO2009098612A2 (en)	2009-08-13
US20110003848A1 (en)	2011-01-06
IL206948A0 (en)	2010-12-30
TW200944524A (en)	2009-11-01
RU2010132639A (ru)	2012-02-10
SI2303267T1 (sl)	2013-09-30
WO2009098612A3 (en)	2009-10-08
ZA201005137B (en)	2011-03-30
TWI391391B (zh)	2013-04-01
AU2009211072B2 (en)	2014-01-23
BRPI0907463A2 (pt)	2019-09-24
CN101939320B (zh)	2013-11-20

Legal Events

Date	Code	Title	Description
2018-08-24	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20180128

Publication	Publication Date	Title
EP2280616A4 (en)	2012-11-21	BODY FOR BABY
EP2257170A4 (en)	2011-08-03	TÉTRAHYDROFUROPYRIDONES
HK1147481A1 (en)	2011-08-12	Polymorphic form
EP2285758A4 (en)	2013-01-02	DISPOSABLE PACKAGING FOR FERTILIZER-PESTICIDE
EP2313147A4 (en)	2013-05-22	crimping
GB0801600D0 (en)	2008-03-05	Microtrench
EP2233305A4 (en)	2010-11-17	GRAPHIC PRINTER
EP2285375A4 (en)	2011-06-15	SPIROAZAINDOLE
GB0802789D0 (en)	2008-03-26	Battery-heated tabard
GB0800389D0 (en)	2008-02-20	Gileo hang-it
GB0800161D0 (en)	2008-02-13	Rota-board
GB0803099D0 (en)	2008-03-26	Pro-bolt
AU4098P (en)	2010-09-29	NPW2 Dianella tasmanica
AU3977P (en)	2010-03-09	PARV01 Myoporum parvifolium
AU3972P (en)	2010-03-02	Tobruk xTriticosecale
AU3935P (en)	2009-12-24	DPV308 Dianella prunina
GB0814613D0 (en)	2008-09-17	Place noticeboard
AU323246S (en)	2008-12-17	Coffeemachine for coffeepods
GB0800635D0 (en)	2008-02-20	Combi-cutter
AU322905S (en)	2008-12-10	LED-Luminaire
GB0800104D0 (en)	2008-02-13	Dissolve-a-bottle
AU2008295V (en)	2009-02-09	Canobolas xTriticosecale
GB0800410D0 (en)	2008-02-20	Q-Box
GB0800481D0 (en)	2008-02-20	Mum-brella
GB0802889D0 (en)	2008-03-26	Dirtbag